tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

IONS Stock Latest News

Ionis Pharmaceuticals price target lowered to $60 from $61 at Raymond James
The FlyIonis Pharmaceuticals price target lowered to $60 from $61 at Raymond James
3d ago
IONS
Ionis Pharmaceuticals price target lowered to $63 from $65 at BofA
PremiumThe Fly
Ionis Pharmaceuticals price target lowered to $63 from $65 at BofA
3d ago
IONS
Ionis Pharmaceuticals price target lowered to $45 from $60 at BMO Capital
PremiumThe Fly
Ionis Pharmaceuticals price target lowered to $45 from $60 at BMO Capital
3d ago
IONS
Ionis Pharmaceuticals: Hold Rating Amid Revenue Growth, Competitive Pressures, and Delayed Catalysts
PremiumRatings
Ionis Pharmaceuticals: Hold Rating Amid Revenue Growth, Competitive Pressures, and Delayed Catalysts
3d ago
IONS
Ionis Pharmaceuticals: Balancing Strong R&D Revenues with Market Challenges – Hold Rating Justified
PremiumRatings
Ionis Pharmaceuticals: Balancing Strong R&D Revenues with Market Challenges – Hold Rating Justified
3d ago
IONS
Ionis Pharmaceuticals price target lowered to $64 from $67 at Citi
PremiumThe FlyIonis Pharmaceuticals price target lowered to $64 from $67 at Citi
3d ago
IONS
Ionis Pharmaceuticals Reports Strong 2024 Results
Premium
Company Announcements
Ionis Pharmaceuticals Reports Strong 2024 Results
3d ago
IONS
Ionis Pharmaceuticals: Positive Sentiment in Earnings Call
Premium
Company Announcements
Ionis Pharmaceuticals: Positive Sentiment in Earnings Call
3d ago
IONS
Optimistic Buy Rating for Ionis Pharmaceuticals Driven by Promising Financial Outlook and Strategic Advancements
PremiumRatings
Optimistic Buy Rating for Ionis Pharmaceuticals Driven by Promising Financial Outlook and Strategic Advancements
3d ago
IONS
Ionis Pharmaceuticals: Strong Revenue Performance and Promising Catalysts Drive Buy Rating
PremiumRatings
Ionis Pharmaceuticals: Strong Revenue Performance and Promising Catalysts Drive Buy Rating
3d ago
IONS
Ionis Pharmaceuticals price target lowered to $38 from $45 at Stifel
PremiumThe Fly
Ionis Pharmaceuticals price target lowered to $38 from $45 at Stifel
3d ago
IONS
Ionis Pharmaceuticals trading resumes
PremiumThe Fly
Ionis Pharmaceuticals trading resumes
4d ago
IONS
Ionis Pharmaceuticals trading halted, volatility trading pause
PremiumThe FlyIonis Pharmaceuticals trading halted, volatility trading pause
4d ago
IONS
Morning Movers: SolarEdge skyrockets following fourth quarter earnings
Premium
The Fly
Morning Movers: SolarEdge skyrockets following fourth quarter earnings
4d ago
ADI
CLH
Ionis Pharmaceuticals sees FY25 revenue $600M, consensus $677.05M
Premium
The Fly
Ionis Pharmaceuticals sees FY25 revenue $600M, consensus $677.05M
4d ago
IONS
Ionis Pharmaceuticals reports Q4 EPS (66c), consensus (84c)
PremiumThe Fly
Ionis Pharmaceuticals reports Q4 EPS (66c), consensus (84c)
4d ago
IONS
Is IONS a Buy, Before Earnings?
PremiumPre-Earnings
Is IONS a Buy, Before Earnings?
6d ago
IONS
Arrowhead price target lowered to $38 from $51 at B. Riley
PremiumThe Fly
Arrowhead price target lowered to $38 from $51 at B. Riley
9d ago
ARWR
IONS
Ionis ‘remains confident in pelacarsen’ after Novartis update on Phase 3 timing
PremiumThe Fly
Ionis ‘remains confident in pelacarsen’ after Novartis update on Phase 3 timing
23d ago
NVS
IONS
Ionis unveils pipeline plan for 2025, expects 4 independent product launches
PremiumThe FlyIonis unveils pipeline plan for 2025, expects 4 independent product launches
1M ago
AZN
IONS
Ionis FDA approval a positive for Arrowhead, says H.C. Wainwright
Premium
The Fly
Ionis FDA approval a positive for Arrowhead, says H.C. Wainwright
2M ago
ARWR
IONS
Ionis Pharmaceuticals reports FDA approval of Tryngolza
Premium
The Fly
Ionis Pharmaceuticals reports FDA approval of Tryngolza
2M ago
IONS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >